Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

(2016) Panos Zanos et al.   NATURE

Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress

(2016) Qian Ren et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Letter to the Editor: R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity

(2016) K. Hashimoto   PSYCHOLOGICAL MEDICINE

NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism

(2015) Carly Kiselycznyk et al.   BEHAVIOURAL BRAIN RESEARCH

Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders

(2015) Y. Ohgi et al.   CURRENT MOLECULAR MEDICINE

Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression

(2015) Ji-chun Zhang et al.   PSYCHOPHARMACOLOGY

Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests

(2015) Arya Haj-Mirzaian et al.   PSYCHOPHARMACOLOGY

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

(2015) C Yang et al.   Translational Psychiatry

Glutamate Receptor Antagonists as Fast-Acting Therapeutic Alternatives for the Treatment of Depression: Ketamine and Other Compounds

(2014) Mark J. Niciu et al.   Annual Review of Pharmacology and Toxicology

GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine

(2014) Oliver H Miller et al.   eLife

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression

(2014) Kenji Hashimoto   Clinical Psychopharmacology and Neuroscience

R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine

(2013) Ji-chun Zhang et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice

(2013) Xian-Cang Ma et al.   PLoS One

Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression

(2012) Kenji Hashimoto   PROGRESS IN NEUROBIOLOGY

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

(2011) Anita E. Autry et al.   NATURE

Roles of glutamate signaling in preclinical and/or mechanistic models of depression

(2011) Kenichi Tokita et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

(2010) N. Li et al.   SCIENCE

Emerging role of glutamate in the pathophysiology of major depressive disorder

(2009) Kenji Hashimoto   BRAIN RESEARCH REVIEWS

Glutamate-based antidepressants: 20 years on

(2009) Phil Skolnick et al.   TRENDS IN PHARMACOLOGICAL SCIENCES